+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neuromodulation Devices Market by Product, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666253
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neuromodulation Devices Market grew from USD 8.66 billion in 2023 to USD 9.79 billion in 2024. It is expected to continue growing at a CAGR of 13.54%, reaching USD 21.07 billion by 2030.

Neuromodulation devices are medical technologies that exert their influence by delivering electrical, chemical, or magnetic stimuli directly to the nervous system to modulate neural activity. The scope and definition of these devices have expanded beyond traditional areas such as chronic pain management to encompass varying applications in treating neurological disorders like Parkinson's disease, epilepsy, and depression, as well as emerging domains in bionics and sensory manipulation. The necessity for these devices is driven by a growing prevalence of such disorders, increased aging population, and advancements in technology leading to more effective, personalized treatments. Key applications include spinal cord stimulation, deep brain stimulation, and vagus nerve stimulation, with notable end-users ranging from hospitals and clinics to home care settings.

Current market insights indicate significant growth potential attributed to the rising adoption of non-invasive neuromodulation techniques, increased investment in research and development, and favorable regulatory scenarios. Emerging opportunities exist in precision medicine, where neuromodulation can be tailored specifically to patient needs, and in developing bioelectronic devices that interact seamlessly with biological tissues. However, challenges such as high costs, complex reimbursement scenarios, and potential side effects pose limitations. Further, technical challenges like device miniaturization and battery performance need addressing.

To seize potential opportunities, stakeholders should focus on innovation in developing user-friendly, cost-effective devices that prioritize patient comfort and ease of use. Collaborations with biotech firms for next-generation neural interfaces and expanding indications through rigorous clinical trials can offer significant advantages. Additionally, areas such as exploring AI-driven algorithms for device modulation and enhancing wireless connectivity for remote monitoring present fruitful research frontiers. The nature of the market is dynamic and competitive, with rapid technological advancements necessitating continual investment in R&D to maintain a competitive edge. Understanding these nuances can help guide effective strategic planning and market positioning within the neuromodulation devices sector.

Understanding Market Dynamics in the Neuromodulation Devices Market

The Neuromodulation Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of neurological disorders and nerve injuries
    • Growing focus on neuromodulation & neurostimulation technologies
    • Expanding applications of neuromodulation
  • Market Restraints
    • High cost of neuromodulation procedures
  • Market Opportunities
    • Government support for research on neurological disorders
    • Development of novel neuromodulation devices
  • Market Challenges
    • Stringent regulatory frameworks and time-consuming approval processes
    • Lack of technical expertise across the globe

Exploring Porter’s Five Forces for the Neuromodulation Devices Market

Porter’s Five Forces framework further strengthens the insights of the Neuromodulation Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Neuromodulation Devices Market

External macro-environmental factors deeply influence the performance of the Neuromodulation Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Neuromodulation Devices Market

The Neuromodulation Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Neuromodulation Devices Market

The Neuromodulation Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Neuromodulation Devices Market

The Neuromodulation Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Avanos Medical, Inc., Axonics, Inc., B. Braun SE, Beijing PINS Medical Co., Ltd., Bioventus, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, Nevro Corp., Second Sight Medical Products Inc., SPR Therapeutics, Inc., Stimwave LLC, and SunMed.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Spinal Cord Stimulators
    • Transcranial Magnetic Stimulators
    • Vagus Nerve Stimulators
  • Application
    • Neurological Disorders
    • Pain Management
    • Respiratory Disorders
  • End User
    • Hospitals
    • Specialty Clinics & Ambulatory Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of neurological disorders and nerve injuries
5.1.1.2. Growing focus on neuromodulation & neurostimulation technologies
5.1.1.3. Expanding applications of neuromodulation
5.1.2. Restraints
5.1.2.1. High cost of neuromodulation procedures
5.1.3. Opportunities
5.1.3.1. Government support for research on neurological disorders
5.1.3.2. Development of novel neuromodulation devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory frameworks and time-consuming approval processes
5.1.4.2. Lack of technical expertise across the globe
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Neuromodulation Devices Market, by Product
6.1. Introduction
6.2. Deep Brain Stimulators
6.3. Sacral Nerve Stimulators
6.4. Spinal Cord Stimulators
6.5. Transcranial Magnetic Stimulators
6.6. Vagus Nerve Stimulators
7. Neuromodulation Devices Market, by Application
7.1. Introduction
7.2. Neurological Disorders
7.3. Pain Management
7.4. Respiratory Disorders
8. Neuromodulation Devices Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics & Ambulatory Centers
9. Americas Neuromodulation Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neuromodulation Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neuromodulation Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
FIGURE 2. NEUROMODULATION DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEUROMODULATION DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS & AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Neuromodulation Devices Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Avanos Medical, Inc.
  • Axonics, Inc.
  • B. Braun SE
  • Beijing PINS Medical Co., Ltd.
  • Bioventus
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Nevro Corp.
  • Second Sight Medical Products Inc.
  • SPR Therapeutics, Inc.
  • Stimwave LLC
  • SunMed

Methodology

Loading
LOADING...

Table Information